Denovo Biopharma
Latest round
- Series D
Last raised
- Dec 2020
Total raised
- $172M
Investors
- 17
About Denovo Biopharma
Established in 2012 and based in Beijing, Denovo Biopharma is a biotechnology company that uses the technology to develop drugs. The company is headquartered in Hangzhou, with a clinical operations center in Beijing and a subsidiary in the United States. Dr. Wen Luo, the company's Chairman and Managing Director, has over 20 years of experience in the biopharmaceutical industry, having worked at Ligand. The company’s main business is the development of antitumor drugs. The company’s self-developed pipeline such as DB102 for glioma, DB106 for acute myeloid leukemia, DB109 for Alzheimer's disease, and DB103 for schizophrenia. The company generates revenues by providing antitumor and drugs for the treatment of the central nervous system.
Who invested in Denovo Biopharma
17 investors across 5 rounds
See all investors in Denovo Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Denovo Biopharma
Who invested in Denovo Biopharma?
Denovo Biopharma has 17 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Denovo Biopharma raised?
Denovo Biopharma has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Denovo Biopharma last raise money?
Denovo Biopharma's most recent round on record is a Series D, in Dec 2020.
What does Denovo Biopharma do?
Established in 2012 and based in Beijing, Denovo Biopharma is a biotechnology company that uses the technology to develop drugs.
Where is Denovo Biopharma headquartered?
Denovo Biopharma is headquartered in Hangzhou, China.
Which VCs invest in companies like Denovo Biopharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Denovo Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Denovo Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.